Fact checked by Nick Blackmer A new study suggests that Parkinson’s disease cases will rise worldwide by 112% by 2050.The ...

Parkinson's cases are set to double by 2050. Learn why it's rising and how lifestyle changes can support long-term brain ...

With Parkinson's indicators varying greatly from person to person, it can often mean that rare symptoms slip through the cracks during early stages of medical analysis. Such the case with one, ...

The condition affects adults primarily older than 65. Though Parkinson’s disease itself is separated into five stages, Parkinson’s disease dementia isn’t as well understood. People with ...

By establishing a metric to quantify brain changes associated with the stages of Parkinson's disease, the study could have several implications. Starting with supporting better diagnosis.

Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

Teleneurorehabilitation provides similar improvement in motor and nonmotor symptoms for patients with Parkinson’s disease as ...

WEHI researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.

With MeiraGTx eyeing up how to take the drug through phase 3 and onto commercialization, Hologen has stepped in. The AI-focused company is handing over $200 million as an upfront payment, as well as ...